{"ticker": {"uuid": "80c22fe7-b5e4-427a-99de-605e99a99364", "symbol": "4565", "name": "Nxera Pharma Co., Ltd.", "exchange": "JPX", "country": "JP", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Nxera Pharma to announce 2Q2026 results on August 7", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQa1FkaEg2cXVQa1haZGlrekRLSng5LVVMQmh3TUZNeGdHVXVPeTRSZ2FYeEFkUjVHRzBZOTBHM095U3NjTThlOGJxV2hiSzNEUE1qajZJb1ZkdjM4YlpaTFpiQ0tOY0gySDJldWI0VWRQcjBwMU9QMnhjS3NJa2ZLTkJRQ3FPMV8yN2FBX1hKRHM4QnB3V2hWc2JPUFIzQW01T00taGdxc3VkSDJC?oc=5", "source_name": "scanx.trade", "published_at": "2026-07-15T10:07:38+00:00", "published_display": "15 Jul 2026 10:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nxera Pharma Webinar for Financial Results Presentation - 2Q2026", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Manila Times", "published_at": "2026-07-15T09:31:42+00:00", "published_display": "15 Jul 2026 09:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nxera Pharma Announces Progress of Out-Licensing of", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwJBVV95cUxPMXFYYnA0S3FoNHAyNUEzM25EWTBLSlgzb1VtemczbDJPbUFKWkN6WXQ5SEpIc3BMRUE4alF4TkVuOHFyMDhSaEtQT3ItYzBiU0xRN2pjdXVqclQ1WWUxTlpuNTRDUnNfMFJrZFVGUzhwSGFKZU1DRl80LVZpV0ZPcVVoN3hZN3gxdDNHbm4zZjI3Uk1BRkhuSDhqVHlMREk3bFlDNDdrbVgxRVNwSTFydkRWaWZPVktEeGR6cUYycVF3SjRiUnNxVjlBWWk0eTNGREZVUVNJQUFvUURrUV94d2luU09iRDNuNHdLM0MyN1NJQUxCNXdha29SUTBkb0VoYXBocXUwVmRVU2p2bTF5bWswbw?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nxera Files Patent Infringement Action in Relation to its miniG Platform Technology", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQa0ZWVXRfck81My04clNKR0RueGo3MjI3SGtLMmF4cWhLX09EWTZNNEV2dVdGSmNrWENlM3JqemlxZ2FjZjExT3R4R3o2LVhFdFFhS1djUDJId1U5SklRclktbEFMZU1kUEVJNEE1M3hydmVJZnYtbGMtOHlSNXowRWc0NkNzVUg3WkRYTmhMZGg?oc=5", "source_name": "Market source", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nxera Pharma\u2019s Partner Centessa Pharmaceuticals to be Acquired by Lilly", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNbzR6dTMyX1NsamM2dXFLOUtmd1dEdkJiXzRIMnZtREZNclJMNWs1bzJwWHNGNzc0eFlJWGN5Ynd1ZzB2NExxY2k0R25CSU1OcU9DOHd5dXlWeHRlaWxxY0oxX0JYOUl6OGVKMmYzTWtld1o3ZHd3LXktX0NtNGF3VllIMFZ5c3duZVRES25nYlF4NGNyNWFkYW53?oc=5", "source_name": "Market source", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nxera Pharma to Receive US$3 Million Milestone Payment from Centessa Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE1UZFFtYkUzZENDMmdlZW0xdnJRcWhuTS1Dem5ManZmeXd5YVp4UnpOeXoxcVl0eE1HakZoNl9rNWtYT2pBWmNJLXVQbk1FaHhTSFZtMUFKR1VTR05fZ2o2TVJ5UkpJNEVUOFdrdFkyajQ0cDhLWDJaYWY3cVdCeDA?oc=5", "source_name": "Market source", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Nxera Pharma to announce 2Q2026 results on August 7", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQa1FkaEg2cXVQa1haZGlrekRLSng5LVVMQmh3TUZNeGdHVXVPeTRSZ2FYeEFkUjVHRzBZOTBHM095U3NjTThlOGJxV2hiSzNEUE1qajZJb1ZkdjM4YlpaTFpiQ0tOY0gySDJldWI0VWRQcjBwMU9QMnhjS3NJa2ZLTkJRQ3FPMV8yN2FBX1hKRHM4QnB3V2hWc2JPUFIzQW01T00taGdxc3VkSDJC?oc=5", "source_name": "scanx.trade", "published_at": "2026-07-15T10:07:38+00:00", "published_display": "15 Jul 2026 10:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nxera Pharma Webinar for Financial Results Presentation - 2Q2026", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Manila Times", "published_at": "2026-07-15T09:31:42+00:00", "published_display": "15 Jul 2026 09:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nxera Pharma Announces Progress of Out-Licensing of", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwJBVV95cUxPMXFYYnA0S3FoNHAyNUEzM25EWTBLSlgzb1VtemczbDJPbUFKWkN6WXQ5SEpIc3BMRUE4alF4TkVuOHFyMDhSaEtQT3ItYzBiU0xRN2pjdXVqclQ1WWUxTlpuNTRDUnNfMFJrZFVGUzhwSGFKZU1DRl80LVZpV0ZPcVVoN3hZN3gxdDNHbm4zZjI3Uk1BRkhuSDhqVHlMREk3bFlDNDdrbVgxRVNwSTFydkRWaWZPVktEeGR6cUYycVF3SjRiUnNxVjlBWWk0eTNGREZVUVNJQUFvUURrUV94d2luU09iRDNuNHdLM0MyN1NJQUxCNXdha29SUTBkb0VoYXBocXUwVmRVU2p2bTF5bWswbw?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nxera Files Patent Infringement Action in Relation to its miniG Platform Technology", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQa0ZWVXRfck81My04clNKR0RueGo3MjI3SGtLMmF4cWhLX09EWTZNNEV2dVdGSmNrWENlM3JqemlxZ2FjZjExT3R4R3o2LVhFdFFhS1djUDJId1U5SklRclktbEFMZU1kUEVJNEE1M3hydmVJZnYtbGMtOHlSNXowRWc0NkNzVUg3WkRYTmhMZGg?oc=5", "source_name": "Market source", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nxera Pharma\u2019s Partner Centessa Pharmaceuticals to be Acquired by Lilly", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNbzR6dTMyX1NsamM2dXFLOUtmd1dEdkJiXzRIMnZtREZNclJMNWs1bzJwWHNGNzc0eFlJWGN5Ynd1ZzB2NExxY2k0R25CSU1OcU9DOHd5dXlWeHRlaWxxY0oxX0JYOUl6OGVKMmYzTWtld1o3ZHd3LXktX0NtNGF3VllIMFZ5c3duZVRES25nYlF4NGNyNWFkYW53?oc=5", "source_name": "Market source", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nxera Pharma to Receive US$3 Million Milestone Payment from Centessa Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE1UZFFtYkUzZENDMmdlZW0xdnJRcWhuTS1Dem5ManZmeXd5YVp4UnpOeXoxcVl0eE1HakZoNl9rNWtYT2pBWmNJLXVQbk1FaHhTSFZtMUFKR1VTR05fZ2o2TVJ5UkpJNEVUOFdrdFkyajQ0cDhLWDJaYWY3cVdCeDA?oc=5", "source_name": "Market source", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 76, "total_relevant": 6, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 6, "score": 50, "total": 6, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 73, "events": [{"event": "general", "label": "Market update", "weight": 2.2, "count": 4}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 919.0, "latest_week": "2026-07-10", "one_week_move": -5.3, "four_week_move": -6.5, "twelve_week_move": -9.3, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": -0.659876, "market_dynamics_buy_signal": false, "relative_strength": -24.604077, "fair_value_gap": -22.0, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 45.5019, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-5.3% over one week, -6.5% over four weeks, trend active, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 56, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 3}, {"label": "scanx.trade", "count": 1}, {"label": "The Manila Times", "count": 1}, {"label": "GlobeNewswire", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 6}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 4}, {"label": "Earnings", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "73/100 classification confidence."}, {"label": "Company focus", "value": "6", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-5.3% over one week, -6.5% over four weeks, trend active, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Nxera Pharma to announce 2Q2026 results on August 7"}], "updated_at": "2026-07-17T13:33:34.678128+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}